This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2000:909:257-9.

doi: 10.1111/j.1749-6632.2000.tb06687.x.

Ibogaine in acute opioid withdrawal. An open label case series

K R Alper¹, H S Lotsof, G M Frenken, D J Luciano, J Bastiaans

Affiliations

PMID: 10911935
DOI: 10.1111/j.1749-6632.2000.tb06687.x

Ibogaine in acute opioid withdrawal. An open label case series

K R Alper et al. Ann N Y Acad Sci. 2000.

. 2000:909:257-9.

doi: 10.1111/j.1749-6632.2000.tb06687.x.

Authors

K R Alper¹, H S Lotsof, G M Frenken, D J Luciano, J Bastiaans

Affiliation

¹ Department of Psychiatry, New York University School of Medicine, New York 10016, USA. Kra1@is9.nyu.edu

PMID: 10911935
DOI: 10.1111/j.1749-6632.2000.tb06687.x

No abstract available

PubMed Disclaimer

Similar articles

Treatment of acute opioid withdrawal with ibogaine.
Alper KR, Lotsof HS, Frenken GM, Luciano DJ, Bastiaans J. Alper KR, et al. Am J Addict. 1999 Summer;8(3):234-42. doi: 10.1080/105504999305848. Am J Addict. 1999. PMID: 10506904 Clinical Trial.
Ibogaine in the treatment of heroin withdrawal.
Mash DC, Kovera CA, Pablo J, Tyndale R, Ervin FR, Kamlet JD, Hearn WL. Mash DC, et al. Alkaloids Chem Biol. 2001;56:155-71. doi: 10.1016/s0099-9598(01)56012-5. Alkaloids Chem Biol. 2001. PMID: 11705106 Review. No abstract available.
A preliminary investigation of ibogaine: case reports and recommendations for further study.
Sheppard SG. Sheppard SG. J Subst Abuse Treat. 1994 Jul-Aug;11(4):379-85. doi: 10.1016/0740-5472(94)90049-3. J Subst Abuse Treat. 1994. PMID: 7966509
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.
Brown TK, Alper K. Brown TK, et al. Am J Drug Alcohol Abuse. 2018;44(1):24-36. doi: 10.1080/00952990.2017.1320802. Epub 2017 May 25. Am J Drug Alcohol Abuse. 2018. PMID: 28541119
100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
Popik P, Layer RT, Skolnick P. Popik P, et al. Pharmacol Rev. 1995 Jun;47(2):235-53. Pharmacol Rev. 1995. PMID: 7568327 Review. No abstract available.

See all similar articles

Cited by

In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis.
Delorenzi JC, Freire-de-Lima L, Gattass CR, de Andrade Costa D, He L, Kuehne ME, Saraiva EM. Delorenzi JC, et al. Antimicrob Agents Chemother. 2002 Jul;46(7):2111-5. doi: 10.1128/AAC.46.7.2111-2115.2002. Antimicrob Agents Chemother. 2002. PMID: 12069962 Free PMC article.
Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration.
Carnicella S, He DY, Yowell QV, Glick SD, Ron D. Carnicella S, et al. Addict Biol. 2010 Oct;15(4):424-33. doi: 10.1111/j.1369-1600.2010.00251.x. Addict Biol. 2010. PMID: 21040239 Free PMC article.
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients.
Knuijver T, Ter Heine R, Schellekens AFA, Heydari P, Lucas L, Westra S, Belgers M, van Oosteren T, Verkes RJ, Kramers C. Knuijver T, et al. J Psychopharmacol. 2024 May;38(5):481-488. doi: 10.1177/02698811241237873. Epub 2024 Mar 22. J Psychopharmacol. 2024. PMID: 38519421 Free PMC article.
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature.
Mosca A, Chiappini S, Miuli A, Mancusi G, Santovito MC, Di Carlo F, Pettorruso M, Corkery JM, Canessa C, Martinotti G, Di Giannantonio M. Mosca A, et al. Curr Neuropharmacol. 2023;21(11):2178-2194. doi: 10.2174/1570159X21666221017085612. Curr Neuropharmacol. 2023. PMID: 36263479 Free PMC article.
Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.
Knuijver T, Schellekens A, Belgers M, Donders R, van Oosteren T, Kramers K, Verkes R. Knuijver T, et al. Addiction. 2022 Jan;117(1):118-128. doi: 10.1111/add.15448. Epub 2021 Aug 9. Addiction. 2022. PMID: 33620733 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information